Full-Time

Senior Solutions Consultant

Posted on 9/4/2026

Definitive Healthcare

Definitive Healthcare

501-1,000 employees

Provides subscription-based healthcare commercial intelligence

Compensation Overview

$106.4k - $152k/yr

+ Bonus + Commission

Framingham, MA, USA

In Person

Bachelor's

Category
Solution Engineering (1)
Required Skills
LLM
Power BI
Python
Data Visualization
R
Epic (EHR)
SQL
Medical Terminology
Tableau
Salesforce
Databricks
Excel/Numbers/Sheets

Get referred to Definitive Healthcare

See people who can refer or advise you

Requirements
  • A college degree or similar real-world experience, ideally in Computer Science, Data Science, Medical Informatics, Economics, or Mathematics.
  • Knowledge of or experience with medical terminology, including DRG, ICD, HCPCS/CPT, and NDC.
  • Very strong expertise in SQL; Databricks experience is preferred.
  • Demonstrated knowledge of or experience with Medicare and/or Commercial Medical Claims and Prescription Claims data.
  • Two to ten years of complex data management responsibilities.
  • Two to ten years of experience quantifying and analyzing healthcare performance metrics.
  • Advanced Excel skills and data visualization experience with tools such as Tableau, Power BI, or Qlik.
  • Ability to translate analysis into actionable recommendations for business audiences.
  • Ability to present technical topics to non-technical stakeholders virtually and in person.
  • Ability to multitask, prioritize, and manage multiple engagements with minimal supervision.
  • Ability to work independently and as part of a team.
  • Critical thinking, written and verbal communication, analytical, organizational, and time-management skills.
  • Strong understanding of emerging artificial intelligence technologies and prompt engineering, with the ability to translate artificial-intelligence-generated output into actionable insights.
Responsibilities
  • Work alongside Sales Executives throughout the opportunity lifecycle, providing analytic support that moves deals from interest to closure.
  • Collaborate with client stakeholders to identify the underlying question, translate ambiguous business problems into detailed documented requirements, and build against those requirements.
  • Deliver tailored demonstrations of Definitive Healthcare products connected to client use cases.
  • Prove the accuracy, depth, and value of healthcare data assets by quantifying, measuring, and analyzing metrics across data sets and identifying outliers and trends.
  • Develop custom data extracts using SQL and other analytic tools, work from report specifications, and recommend modifications that increase client return on data.
  • Validate claims, procedure, and entity volumes; translate requirements into Statements of Work with clear scope, deliverables, timelines, and cost estimates.
  • Present findings and analysis to customers and prospects in person and virtually, holding technical and business conversations in the same meeting.
  • Coordinate appropriate internal parties when client issues arise and remain engaged through resolution, handling competing expectations and working toward solutions.
  • Keep clients current on industry trends, best practices, and relevant product developments, positioning the company as a trusted advisor.
  • Serve as a domain voice internally and externally and apply healthcare commercial intelligence to complex business problems.
  • Bring field insight to Product and Data teams to inform future data assets and capabilities.
  • Drive revenue through compelling demonstrations and understanding client use cases.
  • Partner with Sales Executives as a subject-matter expert.
Desired Qualifications
  • Prior Solutions Engineering, Sales Engineering, Solutions Consulting, or presales experience.
  • Experience selling into or serving consulting, financial services, healthcare IT, staffing, or other organizations operating around the healthcare market.
  • Experience analyzing healthcare cost and utilization trends.
  • Experience with EMR/EHR data such as Epic or Cerner.
  • Programming experience in Python or R.
  • Familiarity with CRM systems such as Salesforce.
  • Experience developing Statements of Work or scoping custom analytics engagements.
  • Databricks experience.
Definitive Healthcare

Definitive Healthcare

View

Definitive Healthcare provides healthcare commercial intelligence by offering a subscription-based database and analytics platform that helps clients in biopharma, medical devices, and provider organizations identify market opportunities and understand competitors. Users access the data, run analyses and reports, and visualize trends to inform sales, partnerships, and outreach to key healthcare stakeholders. The service distinguishes itself with a strict healthcare focus and scalable, domain-specific analytics that turn data into actionable insights. Its goal is to help healthcare organizations accelerate commercial success through practical, data-driven decision-making.

Company Size

501-1,000

Company Stage

IPO

Headquarters

Framingham, Massachusetts

Founded

2011

Get referred to Definitive Healthcare

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 6, 2026 AI platform pilots position DefinitiveHealthcare for late-2026 launch.
  • Q2 2026 adjusted EBITDA reached $14.6 million, showing tighter cost discipline.
  • Special committee received Advent's buyout proposal September 2, 2026, validating strategic value.

What critics are saying

  • Nasdaq bid-price compliance expires December 15, 2026; failure risks delisting and liquidity collapse.
  • Revenue fell 9% in Q2 2026; life sciences weakness still drags.
  • Advent's $1.02 proposal is non-binding; any failed sale leaves a shrinking standalone company.

What makes Definitive Healthcare unique

  • DefinitiveHealthcare's proprietary claims, provider, and affiliation datasets power healthcare commercial intelligence.
  • May 21, 2026 HubSpot and Salesforce integrations embed DefinitiveHealthcare inside customer workflows.
  • Clay Ritchey's September 8, 2026 arrival brings Verato-scale healthcare data operating experience.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Company Match

Flexible Work Hours

Company News

MarketBeat
Sep 5th, 2026
Definitive Healthcare (NASDAQ:DH) downgraded by Wall Street Zen to Hold.

Definitive Healthcare (NASDAQ:DH) downgraded by Wall Street Zen to Hold. September 5, 2026 Key points. * Wall Street Zen downgraded Definitive Healthcare from "buy" to "hold," while the broader analyst consensus is "Reduce," with an average price target of $1.47. * The stock opened at $1.05, up 1%, but remains near its 52-week low of $0.61 and well below its 52-week high of $4.35. Morgan Stanley also lowered its price target from $2.50 to $1.50. * Definitive Healthcare slightly beat quarterly earnings expectations with $0.05 in EPS versus $0.04 forecast, though revenue of $55.20 million fell short of the $55.47 million consensus estimate. * MarketBeat previews the top five stocks to own by October 1st. Definitive Healthcare (NASDAQ:DH - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a research note issued on Saturday, Wall Street Zen reports. A number of other brokerages have also issued reports on DH. Bank of America reissued an "underperform" rating and issued a $0.70 price target on shares of Definitive Healthcare in a research note on Monday, June 29th. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Definitive Healthcare in a research note on Monday. Morgan Stanley cut their price objective on shares of Definitive Healthcare from $2.50 to $1.50 and set an "equal weight" rating on the stock in a report on Tuesday, August 11th. BTIG Research reissued a "neutral" rating on shares of Definitive Healthcare in a research report on Friday. Finally, Robert W. Baird set a $1.10 target price on shares of Definitive Healthcare in a report on Friday, May 8th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, Definitive Healthcare presently has an average rating of "Reduce" and a consensus target price of $1.47. Definitive Healthcare stock up 1.0%. Shares of NASDAQ DH opened at $1.05 on Friday. Definitive Healthcare has a 1 year low of $0.61 and a 1 year high of $4.35. The firm's 50 day moving average price is $0.76 and its 200 day moving average price is $0.94. The firm has a market cap of $112.09 million, a P/E ratio of -0.66, a price-to-earnings-growth ratio of 12.83 and a beta of 1.40. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.86 and a current ratio of 1.86. Definitive Healthcare (NASDAQ:DH - Get Free Report) last issued its quarterly earnings results on Monday, August 10th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.01. Definitive Healthcare had a positive return on equity of 3.55% and a negative net margin of 72.28%.The company had revenue of $55.20 million during the quarter, compared to the consensus estimate of $55.47 million. Definitive Healthcare has set its FY 2026 guidance at 0.180-0.200 EPS and its Q3 2026 guidance at 0.040-0.050 EPS. As a group, sell-side analysts anticipate that Definitive Healthcare will post 0.06 earnings per share for the current year. Institutional trading of Definitive Healthcare. A number of institutional investors and hedge funds have recently bought and sold shares of the business. Raymond James Financial Inc. purchased a new position in Definitive Healthcare in the second quarter valued at approximately $32,000. Schonfeld Strategic Advisors LLC acquired a new position in Definitive Healthcare during the fourth quarter valued at approximately $35,000. HRT Financial LP purchased a new stake in Definitive Healthcare during the fourth quarter worth approximately $47,000. ExodusPoint Capital Management LP purchased a new stake in Definitive Healthcare during the fourth quarter worth approximately $47,000. Finally, M&T Bank Corp acquired a new stake in shares of Definitive Healthcare in the fourth quarter worth $49,000. Institutional investors and hedge funds own 98.67% of the company's stock. About Definitive Healthcare. Definitive Healthcare NASDAQ: DH is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources - including claims, government registries, commercial filings and proprietary research - to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes. Discover more investment 5G stocks guide The company's flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Continue following MarketBeat Before you consider Definitive Healthcare, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Definitive Healthcare wasn't on the list. While Definitive Healthcare currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys. With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Yahoo Finance
Sep 3rd, 2026
Advent International submits $1.02-per-share buyout proposal for Definitive Healthcare

Definitive Healthcare shares jumped 13% after Advent International submitted a non-binding proposal to acquire shares it doesn't already own for $1.02 per share in cash. The offer represents a 36% premium to the company's 60-day volume-weighted average trading price of $0.75 per share as of 31 August. The proposal covers all outstanding Class A common stock and Definitive OpCo Units not owned by Advent and stockholder Jason Krantz. Advent assumes Krantz, the company's founder and Executive Chairman, would roll over his equity into the surviving company. The transaction requires approval from Definitive Healthcare's Special Committee of independent directors. Advent stated the proposal is not subject to a financing condition but remains non-binding. Separately, Definitive Healthcare appointed Clay Ritchey as CEO, effective 8 September, replacing Kevin Coop.

Associated Press
Sep 2nd, 2026
Clay Ritchey appointed CEO of Definitive Healthcare, succeeds Kevin Coop

Definitive Healthcare has appointed Clay Ritchey as chief executive officer, effective 8 September 2026. He succeeds Kevin Coop, who departed on 31 August after serving as CEO since June 2024. Ritchey brings over 25 years of experience in healthcare data and technology markets. He most recently served as CEO of Verato, a healthcare master data management company. Previously, he held senior leadership positions at Evariant, Imprivata, and Equinox Healthcare. Definitive Healthcare, which provides healthcare market data and analytics, is preparing to launch an AI-powered platform combining its datasets with conversational AI and workflows. Ritchey said he aims to accelerate the company's return to growth and help customers gain more value from the firm's data assets. Jason Krantz, chairman of Definitive Healthcare's board, praised Ritchey's track record of generating profitable growth.

GlobeNewswire
Sep 2nd, 2026
Definitive Healthcare appoints Clay Ritchey as CEO.

Definitive Healthcare appoints Clay Ritchey as CEO. Mr. Ritchey brings more than 25 years of deep healthcare expertise to Definitive. FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) - Definitive Healthcare Corp. ("Definitive Healthcare") (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that its Board of Directors has appointed Clay Ritchey as the Company's next Chief Executive Officer and as a member of the Board of Directors, each effective September 8, 2026. Mr. Ritchey succeeds Kevin Coop, who departed as CEO and as a member of the Board of Directors, effective August 31, 2026. Mr. Coop had served as CEO since June 2024. Jason Krantz, Chairman of the Board of Definitive Healthcare, said, "We are excited to welcome Clay as our new CEO. He is a visionary leader with more than 25 years of experience across the healthcare master data and technology markets. Clay has a proven track record of generating faster, durable, and profitable growth in his prior senior leadership roles. In addition, Clay has a deep conviction that AI is posed to fundamentally reshape healthcare and that Definitive Healthcare is uniquely positioned to lead that shift as the industry's premier healthcare commercial intelligence player." Mr. Ritchey joins Definitive Healthcare after most recently serving as CEO of Verato, a leading healthcare master data management company. Prior to Verato, he held senior leadership positions at multiple healthcare focused companies, including as CEO of Evariant prior to its acquisition by Healthgrades, as CMO of Imprivata and CEO of Equinox Healthcare. Earlier in his career he held senior marketing and go-to-market positions with Hill-Rom and Kronos. "I'm thrilled to be joining Definitive Healthcare to help accelerate the company's return to growth," said Mr. Ritchey. "Definitive Healthcare operates in a large and attractive market where our proprietary datasets and growing portfolio of solutions help customers solve critical business challenges that create extraordinary value. And with the upcoming release of our new AI powered platform, which combines our best-in-class healthcare data with conversational AI and workflows, our customers will be able to gain even more leverage and value from our powerful data assets. I'm excited to hit the ground running alongside our customers and employees to innovate faster and deliver consistent top and bottom-line growth." About Definitive Healthcare Definitive Healthcare is a data and analytics company focused on the business side of healthcare. The healthcare market is complex - our data makes it clearer. We cut through the noise to deliver the insights that healthcare organizations and companies need to make smarter, faster, more strategic decisions. Because when our customers succeed, healthcare gets better for everyone. Learn more at definitivehc.com. Forward-Looking Statements This press release includes forward-looking statements that reflect our current views with respect to future events and financial performance. Such statements are provided under the "safe harbor" protection of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts, and can generally be identified by words or phrases written in the future tense and/or preceded by words such as "likely," "will," "should," "may," "anticipates," "intends," "plans," "seeks," "believes," "estimates," "expects," "continues," "assumes," "would," "potentially" or similar words or variations thereof, or the negative thereof, references to future periods, or by the inclusion of forecasts or projections, but these terms are not the exclusive means of identifying such statements. Examples of forward-looking statements include, but are not limited to, statements we make regarding our outlook, financial guidance, the benefits of our healthcare commercial intelligence solutions, our overall future prospects, customer behaviors and use of our solutions, the market, industry and macroeconomic environment, our plans to improve our operational and financial performance and our business, our ability to execute on our plans, customer growth, including our upsell and cross-sell opportunities, and our ability to successfully transition executive leadership. Forward-looking statements in this press release are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. As a result, our actual results may differ materially from those contemplated by the forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements include the following: global geopolitical tension and difficult macroeconomic conditions; actual or potential changes in international, national, regional and local economic, business and financial conditions, including tariffs, sanctions, trade barriers, recessions, fluctuating inflation, high interest rates, volatility in the capital markets and related market uncertainty; our inability to acquire new customers and generate additional revenue from existing customers; our inability to generate sales of subscriptions to our platform or any decline in demand for our platform and the data we offer; the competitiveness of the market in which we operate and our ability to compete effectively; the failure to maintain and improve our platform, or develop new modules or insights for healthcare commercial intelligence; the inability to obtain and maintain accurate, comprehensive or reliable data, which could result in reduced demand for our platform; the loss of our access to our data providers; the failure to respond to advances in healthcare commercial intelligence; an inability to attract new customers and expand subscriptions of current customers; our ability to successfully transition executive leadership; and the possibility that our security measures are breached or unauthorized access to data is otherwise obtained. Additional factors or events that could cause our actual performance to differ from these forward-looking statements may emerge from time to time, and it is not possible for us to predict all of them. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, our actual financial condition, results of operations, future performance and business may vary in material respects from the performance projected in these forward-looking statements. For additional discussion of factors that could impact our operational and financial results, refer to our Quarterly Report on Form 10-Q for the three months ended June 30, 2026 that will be filed following this earnings release, as well as our Current Reports on Form 8-K and other subsequent SEC filings, which are or will be available on the Investor Relations page of our website at ir.definitivehc.com and on the U.S. Securities and Exchange Commission ("SEC") website at www.sec.gov. All information in this press release speaks only as of the date on which it is made. We undertake no obligation to publicly update this information, whether as a result of new information, future developments or otherwise, except as may be required by law. Definitive Healthcare intends to use its website as a distribution channel of material company information. Financial and other important information regarding the Company is routinely posted on and accessible through the Company's website at definitivehc.com. Accordingly, you should monitor the investor relations portion of our website at ir.definitivehc.com in addition to following our press releases, SEC filings, and public conference calls and webcasts. In addition, you may automatically receive email alerts and other information about the Company when you enroll your email address by visiting the "Email Alerts" section of our investor relations page at ir.definitivehc.com. Investor Contact: Brian Denyeau ICR for Definitive Healthcare [email protected] 646-277-1251

Yahoo Finance
Aug 10th, 2026
Definitive Healthcare Q2 revenue falls 9% to $55.2M as life sciences recovery lags

Definitive Healthcare reported Q2 fiscal 2026 revenue of $55.2 million, down 9% year-over-year, while adjusted EBITDA of $14.6 million exceeded guidance. The company generated $11.6 million in unlevered free cash flow during the quarter. CEO Kevin Coop said the firm's diversified and provider businesses, representing over 60% of revenue, are recovering faster than its life sciences segment. Trailing-12-month net dollar retention improved for the second consecutive quarter. The biopharma segment posted its strongest new-business quarter in three years outside Q4, including four returning customers. CFO Casey Heller noted that claims-data-related downselling has begun to lessen after adding new data sources, though it remains early to assess full impact.